13D Filing: Growth Equity Opportunities Iv, Llc and Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because...

Keep Reading →